Compare Davita Inc (DVA) vs SYSCO Corporation (SYY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs SYSCO Corporation — how do they compare? Davita Inc trades at $175.04 (market cap $11.29B), while SYSCO Corporation trades at $78.07 (market cap $38.47B). The key difference: SYSCO Corporation is far larger — about 3.4× Davita Inc's market cap, and SYSCO Corporation pays a 2.81% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and SYSCO Corporation for 77 Days on average.
| DVA | SYY | |
|---|---|---|
Market Cap | $11.29B | $38.47B |
Volume | 582,204 | 4,808,465 |
Sector | Health | Consumer Staples |
52-Week High | $240.96 | $91.16 |
52-Week Low | $103.87 | $69.30 |
Typical Hold Time | 113 Days | 77 Days |
Enterprise Value | $24.01B | $51.65B |
Dividend Yield | — | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $176.78, down 2.01% today, showing technical bearish signals with price near key support at $175. Fundamentally, the company demonstrates solid earnings performance with three consecutive quarterly beats and attractive valuation metrics including a P/E of 14.98 and P/S of 0.88. Recent expansion of value-based care partnerships with Humana positions the company for continued growth in kidney care services.
The stock presents a compelling value opportunity with analyst consensus target of $235.67 offering 33% upside potential, though investors face risks from regulatory pressures and narrowing profit margins. Warren Buffett's significant ownership (45%) and institutional buying activity provide confidence, but the bearish technical outlook and mixed analyst ratings (43% Buy, 52% Hold) suggest cautious optimism is warranted.
Sysco (SYY) trades at $76.79, down 0.85% on the day, with a bearish technical signal despite recent earnings beats. The company maintains steady revenue growth, reaching $81.37B in 2025, though net margins remain thin at 2.08%. Recent developments include a $500M AI efficiency program and a $1.5B senior notes offering, positioning for future growth while managing debt levels near 50% of assets.
Outlook remains cautiously optimistic with 60% analyst buy ratings and an $85.75 price target suggesting 12% upside. Key risks include margin pressure from inflation and competitive threats, while the AI initiative and consistent dividend payments provide stability. The stock offers value at a P/S of 0.44 but requires monitoring of debt management and execution on efficiency targets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About SYSCO Corporation
Sysco is the largest U.S. food-service distributor, boasting 17% market share of the highly fragmented food-service distribution industry. Sysco distributes over 400,000 food and nonfood products to restaurants (63% of revenue), healthcare facilities (8%), education and government buildings (8%), travel and leisure (7%), and other locations (14%) where individuals consume away-from-home meals. In fiscal 2022, 82% of the firm's revenue was U.S.-based, with 7% from Canada, 4% from the U.K., 2% from France, and 4% other.
Read more on SYY →
